Open AccessThe strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease
Author(s) -
N. V. Topchiy,
А. С. Топорков
Publication year - 2018
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2018-3-32-41
Subject(s) - reflux , proton pump inhibitor , disease , drug , gastroenterology , pharmacokinetics , medicine , lansoprazole , pharmacology , gastric acid , gerd , randomized controlled trial , clinical trial , secretion , omeprazole